Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
Netflix
NFLX
|
+$753M |
| 3 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$749M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$662M |
| 5 |
Walmart Inc
WMT
|
+$405M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$426M |
| 3 |
Meta Platforms (Facebook)
META
|
+$372M |
| 4 |
TSMC
TSM
|
+$331M |
| 5 |
Pinduoduo
PDD
|
+$319M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.23% |
| 2 | Technology | 1.7% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Communication Services | 0.67% |
| 5 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11801
CALL
Cato Corp
CATO
$53.1M
| $43K | ﹤0.01% |
13,900
-137,500
| -91% | -$505K |
|
11802
PUT
ABVC BioPharma
ABVC
$21.2M
| $42.8K | ﹤0.01% |
+20,100
| New | +$53.9K |
|
11803
CXApp
CXAI
$9.26M
| $42.7K | ﹤0.01% |
2,570
+1,197
| +87% | +$34.3K |
|
|
NOTE
11804
DELISTED
FiscalNote
NOTE
| $42.6K | ﹤0.01% |
29,001
-13,864
| -32% | -$42.1K |
|
11805
Ispire Technology
ISPR
$81.5M
| $42.5K | ﹤0.01% |
+15,167
| New | +$35.2K |
|
|
NVNO
11806
enVVeno Medical
NVNO
$7.81M
| $42.5K | ﹤0.01% |
3,781
-632
| -14% | -$12.3K |
|
11807
Coffee Holding Co
JVA
$19.8M
| $42.4K | ﹤0.01% |
10,921
-2,042
| -16% | -$8.08K |
|
11808
Quetta Acquisition Corp Right
QETAR
| $42.3K | ﹤0.01% |
20,751
-4,860
| -19% | -$8.46K |
|
11809
Deswell Industries
DSWL
$47.8M
| $42.3K | ﹤0.01% |
+12,197
| New | +$43.4K |
|
11810
Cryo-Cell International
CCEL
$34.1M
| $42.1K | ﹤0.01% |
12,253
+1,191
| +11% | +$4.95K |
|
|
AMTD
11811
AMTD IDEA Group
AMTD
$73.2M
| $42.1K | ﹤0.01% |
42,800
+2,237
| +6% | +$2.36K |
|
11812
PUT
iHeartMedia
IHRT
$416M
| $42K | ﹤0.01% |
10,100
-334,000
| -97% | -$1.25M |
|
11813
Cibus
CBUS
$128M
| $42K | ﹤0.01% |
+24,128
| New | +$36K |
|
11814
Claros Mortgage Trust
CMTG
$233M
| $41.9K | ﹤0.01% |
13,701
-22,780
| -62% | -$74.3K |
|
11815
Pliant Therapeutics
PLRX
$71.2M
| $41.7K | ﹤0.01% |
34,201
-39,753
| -54% | -$59.7K |
|
11816
authID Inc
AUID
$8.4M
| $41.6K | ﹤0.01% |
+47,586
| New | +$90.2K |
|
|
ACH
11817
CALL
Accendra Health
ACH
$93.1M
| $41.4K | ﹤0.01% |
14,800
-221,500
| -94% | -$792K |
|
11818
Sphere 3D
ANY
$22.3M
| $40.9K | ﹤0.01% |
13,749
+2,890
| +27% | +$17.3K |
|
11819
CALL
BeyondSpring
BYSI
$26.3M
| $40.8K | ﹤0.01% |
25,000
-6,500
| -21% | -$12.5K |
|
11820
Flux Power
FLUX
$13.6M
| $40.6K | ﹤0.01% |
31,967
-27,699
| -46% | -$81.7K |
|
11821
Eledon Pharmaceuticals
ELDN
$270M
| $40.5K | ﹤0.01% |
26,797
-1,903
| -7% | -$4.52K |
|
11822
PUT
Apyx Medical
APYX
$126M
| $39.9K | ﹤0.01% |
+11,400
| New | +$39.8K |
|
11823
Aware
AWRE
$26.8M
| $39.9K | ﹤0.01% |
+21,431
| New | +$48.4K |
|
11824
InflaRx
IFRX
$335M
| $39.8K | ﹤0.01% |
39,373
-102,682
| -72% | -$128K |
|
11825
CytoMed Therapeutics
GDTC
$11.2M
| $39.7K | ﹤0.01% |
+29,829
| New | +$57.8K |
|
Similar funds
Jeff Yass's Q4 2025 Portfolio in Review
As of Q4 2025, Jeff Yass held 14,094 positions worth $868B, down 0.79% from $875B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2025 filing shows 1,864 new, 4,890 increased, 5,380 reduced and 1,914 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2025 buy was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2025, an estimated $1.17B increase.
- Jeff Yass's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.08B.
- Jeff Yass fully exited Innovator US Equity Power Buffer ETF September in Q4 2025, selling an estimated $26.5M.
- Jeff Yass's ten largest holdings make up 24% of its $868B portfolio in Q4 2025.
- Jeff Yass opened 1,864 new positions and closed 1,914 in Q4 2025.
- Jeff Yass's portfolio value fell 0.79% quarter-over-quarter to $868B.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.